The powerful chemotherapy drug cisplatin has been used since the late 1970s to treat a variety of cancers. It’s highly effective against solid tumors and is often a core element of treatment for children with brain and spinal cord tumors, neuroblastoma, and rhabdomyosarcoma.
New machine learning tool predicts a child’s personal risk for cisplatin-induced hearing loss
